{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:56:41Z","timestamp":1791806201665,"version":"4.3.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Japan Leukemia Research Fund"},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24ck0106935"],"award-info":[{"award-number":["JP24ck0106935"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22ama221514h0001"],"award-info":[{"award-number":["22ama221514h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23ama221514h002"],"award-info":[{"award-number":["23ama221514h002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22cm0106xxxh000x"],"award-info":[{"award-number":["JP22cm0106xxxh000x"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23ama221505h0002"],"award-info":[{"award-number":["23ama221505h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20H00528"],"award-info":[{"award-number":["JP20H00528"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K19405"],"award-info":[{"award-number":["JP21K19405"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K18264"],"award-info":[{"award-number":["JP23K18264"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006680","name":"Takeda Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006680","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005683","name":"Kyoto University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005683","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Lineage switching (LS) is the conversion of cancer cell lineage during the course of a disease. LS in leukemia cell lineage facilitates cancer cells escaping targeting strategy like CD19 targeted immunotherapy. However, the genetic and biological mechanisms underlying immune evasion by LS leukemia cells are not well understood. Here, we conduct a multi-omics analysis of patient samples and find that lineage-switched acute myeloid leukemia (LS AML) cells with <jats:italic>KMT2A<\/jats:italic> rearrangement (<jats:italic>KMT2A-r<\/jats:italic>) possess monocytic myeloid derived suppressor cell (M-MDSC)-like characteristics. Single-cell mass cytometry analysis reveals an increase in the M-MDSC like LS AML as compared to those of lineage-consistent <jats:italic>KMT2A-r<\/jats:italic> AML, and single-cell transcriptomics identify distinct expression patterns of immunoregulatory genes within this population. Furthermore, in vitro assays confirm the immunosuppressive capacity of LS AML cells against T cells, which is analogous to that of MDSCs. These data provide insight into the immunological aspects of the complex pathogenesis of LS AML, as well as development of future treatments.<\/jats:p>","DOI":"10.1038\/s41467-025-63271-y","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T13:13:15Z","timestamp":1756213995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Multi-omics analysis identifies an M-MDSC-like immunosuppressive phenotype in lineage-switched AML with KMT2A rearrangement"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1846-4500","authenticated-orcid":false,"given":"Takashi","family":"Mikami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-4960","authenticated-orcid":false,"given":"Itaru","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9127-807X","authenticated-orcid":false,"given":"Akira","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minenori","family":"Eguchi-Ishimae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0472-4663","authenticated-orcid":false,"given":"Tatsuya","family":"Kamitori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Tasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6935-5120","authenticated-orcid":false,"given":"Hirohito","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3487-3307","authenticated-orcid":false,"given":"Tomoya","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Uchihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Namikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5738-4138","authenticated-orcid":false,"given":"Shinichi","family":"Tsujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Hamabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1080-0936","authenticated-orcid":false,"given":"Kazushi","family":"Izawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Miyamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1520-7007","authenticated-orcid":false,"given":"Daisuke","family":"Tomizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidemi","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8727-1732","authenticated-orcid":false,"given":"Mariko","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seishi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7580-9184","authenticated-orcid":false,"given":"Masatoshi","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3462-1003","authenticated-orcid":false,"given":"James Badger","family":"Wing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2452-6520","authenticated-orcid":false,"given":"Junko","family":"Takita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"63271_CR1","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1002\/ajh.23266","volume":"87","author":"JG Rossi","year":"2012","unstructured":"Rossi, J. G. et al. Lineage switch in childhood acute leukemia: an unusual event with poor outcome. Am. J. Hematol. 87, 890\u2013897 (2012).","journal-title":"Am. J. Hematol."},{"key":"63271_CR2","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1182\/bloodadvances.2018018093","volume":"2","author":"M Wolfl","year":"2018","unstructured":"Wolfl, M. et al. Spontaneous reversion of a lineage switch following an initial blinatumomab-induced ALL-to-AML switch in MLL-rearranged infant ALL. Blood Adv. 2, 1382\u20131385 (2018).","journal-title":"Blood Adv."},{"key":"63271_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/ijlh.13923","volume":"44","author":"JH Kurzer","year":"2022","unstructured":"Kurzer, J. H. & Weinberg, O. K. To B- or not to B-: a review of lineage switched acute leukemia. Int. J. Lab Hematol. 44, 64\u201370 (2022).","journal-title":"Int. J. Lab Hematol."},{"key":"63271_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12320","volume":"7","author":"E Jacoby","year":"2016","unstructured":"Jacoby, E. et al. CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity. Nat. Commun. 7, 12320 (2016).","journal-title":"Nat. Commun."},{"key":"63271_CR5","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1182\/blood-2023-182293","volume":"142","author":"SK Silbert","year":"2023","unstructured":"Silbert, S. K. et al. Project evolve, evaluation of lineage switch (LS), an International Initiative: preliminary results reveal dismal outcomes in patients with LS. Blood 142, 4202\u20134202 (2023).","journal-title":"Blood"},{"key":"63271_CR6","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/s41375-023-01877-1","volume":"37","author":"C Meyer","year":"2023","unstructured":"Meyer, C. et al. The KMT2A recombinome of acute leukemias in 2023. Leukemia 37, 988\u20131005 (2023).","journal-title":"Leukemia"},{"key":"63271_CR7","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3390\/cells8111341","volume":"8","author":"O Britten","year":"2019","unstructured":"Britten, O., Ragusa, D., Tosi, S. & Kamel, Y. M. MLL-rearranged acute leukemia with t(4;11)(q21;q23)-current treatment options. Is there a role for CAR-T cell therapy? Cells 8, 1341 (2019).","journal-title":"Cells"},{"key":"63271_CR8","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.celrep.2016.06.046","volume":"16","author":"NA Barrett","year":"2016","unstructured":"Barrett, N. A. et al. Mll-AF4 confers enhanced self-renewal and lymphoid potential during a restricted window in development. Cell Rep. 16, 1039\u20131054 (2016).","journal-title":"Cell Rep."},{"key":"63271_CR9","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1182\/blood.2021013442","volume":"139","author":"C Chen","year":"2022","unstructured":"Chen, C. et al. Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemia. Blood 139, 2198\u20132211 (2022).","journal-title":"Blood"},{"key":"63271_CR10","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1182\/blood.2021015036","volume":"140","author":"R Tirtakusuma","year":"2022","unstructured":"Tirtakusuma, R. et al. Epigenetic regulator genes direct lineage switching in MLL\/AF4 leukemia. Blood 140, 1875\u20131890 (2022).","journal-title":"Blood"},{"key":"63271_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12150","volume":"7","author":"V Bronte","year":"2016","unstructured":"Bronte, V. et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat. Commun. 7, 12150 (2016).","journal-title":"Nat. Commun."},{"key":"63271_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000168","volume":"3","author":"N Bizymi","year":"2019","unstructured":"Bizymi, N. et al. Myeloid-derived suppressor cells in hematologic diseases: promising biomarkers and treatment targets. Hemasphere 3, e168 (2019).","journal-title":"Hemasphere"},{"key":"63271_CR13","doi-asserted-by":"publisher","first-page":"7007","DOI":"10.1002\/cam4.3360","volume":"9","author":"SY Hyun","year":"2020","unstructured":"Hyun, S. Y. et al. Immunosuppressive role of CD11b(+) CD33(+) HLA-DR(-) myeloid-derived suppressor cells-like blast subpopulation in acute myeloid leukemia. Cancer Med. 9, 7007\u20137017 (2020).","journal-title":"Cancer Med."},{"key":"63271_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nm.4439","volume":"24","author":"H Bolouri","year":"2018","unstructured":"Bolouri, H. et al. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions. Nat. Med. 24, 103\u2013112 (2018).","journal-title":"Nat. Med."},{"key":"63271_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet 34, 267\u2013273 (2003).","journal-title":"Nat. Genet"},{"key":"63271_CR16","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63271_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/cyto.b.21280","volume":"92","author":"C Lambert","year":"2017","unstructured":"Lambert, C., Preijers, F., Yanikkaya Demirel, G. & Sack, U. Monocytes and macrophages in flow: an ESCCA initiative on advanced analyses of monocyte lineage using flow cytometry. Cytom. B Clin. Cytom. 92, 180\u2013188 (2017).","journal-title":"Cytom. B Clin. Cytom."},{"key":"63271_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","volume":"21","author":"F Veglia","year":"2021","unstructured":"Veglia, F., Sanseviero, E. & Gabrilovich, D. I. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat. Rev. Immunol. 21, 485\u2013498 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"63271_CR19","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1189\/jlb.1A0215-068RR","volume":"100","author":"S Nam","year":"2016","unstructured":"Nam, S. et al. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function. J. Leukoc. Biol. 100, 1273\u20131284 (2016).","journal-title":"J. Leukoc. Biol."},{"key":"63271_CR20","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1007\/s00262-020-02605-9","volume":"69","author":"P Metzger","year":"2020","unstructured":"Metzger, P. et al. Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model. Cancer Immunol. Immunother. 69, 2101\u20132112 (2020).","journal-title":"Cancer Immunol. Immunother."},{"key":"63271_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108571","volume":"33","author":"T Kwak","year":"2020","unstructured":"Kwak, T. et al. Distinct populations of immune-suppressive macrophages differentiate from monocytic myeloid-derived suppressor cells in cancer. Cell Rep. 33, 108571 (2020).","journal-title":"Cell Rep."},{"key":"63271_CR22","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1111\/cas.13809","volume":"109","author":"H Shi","year":"2018","unstructured":"Shi, H. et al. Chemokine (C-X-C motif) ligand 1 and CXCL2 produced by tumor promote the generation of monocytic myeloid-derived suppressor cells. Cancer Sci. 109, 3826\u20133839 (2018).","journal-title":"Cancer Sci."},{"key":"63271_CR23","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nbt.2594","volume":"31","author":"AD Amir","year":"2013","unstructured":"Amir, A. D. et al. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat. Biotechnol. 31, 545\u2013552 (2013).","journal-title":"Nat. Biotechnol."},{"key":"63271_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jim.2012.04.004","volume":"381","author":"A Kotsakis","year":"2012","unstructured":"Kotsakis, A. et al. Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples. J. Immunol. Methods 381, 14\u201322 (2012).","journal-title":"J. Immunol. Methods"},{"key":"63271_CR25","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s40425-019-0674-1","volume":"7","author":"MC Apodaca","year":"2019","unstructured":"Apodaca, M. C. et al. Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells. J. Immunother. Cancer 7, 230 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"63271_CR26","doi-asserted-by":"publisher","first-page":"e0243643","DOI":"10.1371\/journal.pone.0243643","volume":"15","author":"K Shirasuna","year":"2020","unstructured":"Shirasuna, K. et al. Correlation analysis of the proportion of monocytic myeloid-derived suppressor cells in colorectal cancer patients. PLoS One 15, e0243643 (2020).","journal-title":"PLoS One"},{"key":"63271_CR27","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/sj.leu.2404675","volume":"21","author":"R Ratei","year":"2007","unstructured":"Ratei, R. et al. Discriminant function analysis as decision support system for the diagnosis of acute leukemia with a minimal four color screening panel and multiparameter flow cytometry immunophenotyping. Leukemia 21, 1204\u20131211 (2007).","journal-title":"Leukemia"},{"key":"63271_CR28","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41591-020-0783-x","volume":"26","author":"AG Tsai","year":"2020","unstructured":"Tsai, A. G. et al. Multiplexed single-cell morphometry for hematopathology diagnostics. Nat. Med. 26, 408\u2013417 (2020).","journal-title":"Nat. Med."},{"key":"63271_CR29","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","volume":"30","author":"M Miyara","year":"2009","unstructured":"Miyara, M. et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30, 899\u2013911 (2009).","journal-title":"Immunity"},{"key":"63271_CR30","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","volume":"50","author":"JB Wing","year":"2019","unstructured":"Wing, J. B., Tanaka, A. & Sakaguchi, S. Human FOXP3(+) regulatory T cell heterogeneity and function in autoimmunity and cancer. Immunity 50, 302\u2013316 (2019).","journal-title":"Immunity"},{"key":"63271_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1021612","volume":"13","author":"D Xu","year":"2022","unstructured":"Xu, D. et al. Myeloid-derived suppressor cell: a crucial player in autoimmune diseases. Front. Immunol. 13, 1021612 (2022).","journal-title":"Front. Immunol."},{"key":"63271_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"63271_CR33","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13, 2498\u20132504 (2003).","journal-title":"Genome Res"},{"key":"63271_CR34","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1093\/bioinformatics\/btx792","volume":"34","author":"C Weinreb","year":"2018","unstructured":"Weinreb, C., Wolock, S. & Klein, A. M. SPRING: a kinetic interface for visualizing high dimensional single-cell expression data. Bioinformatics 34, 1246\u20131248 (2018).","journal-title":"Bioinformatics"},{"key":"63271_CR35","doi-asserted-by":"publisher","first-page":"eadj4407","DOI":"10.1126\/sciadv.adj4407","volume":"9","author":"A Nishimura","year":"2023","unstructured":"Nishimura, A. et al. Myeloid\/natural killer (NK) cell precursor acute leukemia as a distinct leukemia type. Sci. Adv. 9, eadj4407 (2023).","journal-title":"Sci. Adv."},{"key":"63271_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.101389","volume":"3","author":"JE Choi","year":"2022","unstructured":"Choi, J. E. et al. Isolation of human and mouse myeloid-derived suppressor cells for metabolic analysis. STAR Protoc. 3, 101389 (2022).","journal-title":"STAR Protoc."},{"key":"63271_CR37","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00280-020-04045-9","volume":"85","author":"H Goto","year":"2020","unstructured":"Goto, H. et al. Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia. Cancer Chemother. Pharm. 85, 773\u2013783 (2020).","journal-title":"Cancer Chemother. Pharm."},{"key":"63271_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01657-y","volume":"21","author":"Y Wu","year":"2022","unstructured":"Wu, Y., Yi, M., Niu, M., Mei, Q. & Wu, K. Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy. Mol. Cancer 21, 184 (2022).","journal-title":"Mol. Cancer"},{"key":"63271_CR39","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","volume":"6","author":"K Li","year":"2021","unstructured":"Li, K. et al. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct. Target Ther. 6, 362 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"63271_CR40","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10555-023-10079-1","volume":"42","author":"K Cole","year":"2023","unstructured":"Cole, K., Al-Kadhimi, Z. & Talmadge, J. E. Role of myeloid-derived suppressor cells in tumor recurrence. Cancer Metastasis Rev. 42, 113\u2013142 (2023).","journal-title":"Cancer Metastasis Rev."},{"key":"63271_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.103164","volume":"157","author":"S Taghiloo","year":"2021","unstructured":"Taghiloo, S. & Asgarian-Omran, H. Immune evasion mechanisms in acute myeloid leukemia: A focus on immune checkpoint pathways. Crit. Rev. Oncol. Hematol. 157, 103164 (2021).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"63271_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41375-021-01350-x","volume":"36","author":"S Tettamanti","year":"2022","unstructured":"Tettamanti, S., Pievani, A., Biondi, A., Dotti, G. & Serafini, M. Catch me if you can: how AML and its niche escape immunotherapy. Leukemia 36, 13\u201322 (2022).","journal-title":"Leukemia"},{"key":"63271_CR43","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1046\/j.1365-2249.2001.01692.x","volume":"126","author":"JK Orleans-Lindsay","year":"2001","unstructured":"Orleans-Lindsay, J. K., Barber, L. D., Prentice, H. G. & Lowdell, M. W. Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function\u2013implications for the adoptive immunotherapy of leukaemia. Clin. Exp. Immunol. 126, 403\u2013411 (2001).","journal-title":"Clin. Exp. Immunol."},{"key":"63271_CR44","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.4049\/jimmunol.167.10.6021","volume":"167","author":"AG Buggins","year":"2001","unstructured":"Buggins, A. G. et al. Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways. J. Immunol. 167, 6021\u20136030 (2001).","journal-title":"J. Immunol."},{"key":"63271_CR45","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1182\/blood-2013-01-480129","volume":"122","author":"F Mussai","year":"2013","unstructured":"Mussai, F. et al. Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment. Blood 122, 749\u2013758 (2013).","journal-title":"Blood"},{"key":"63271_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-023-00475-8","volume":"11","author":"S Wang","year":"2023","unstructured":"Wang, S., Zhao, X., Wu, S., Cui, D. & Xu, Z. Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies. Biomark. Res. 11, 34 (2023).","journal-title":"Biomark. Res."},{"key":"63271_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2023.113441","volume":"515","author":"VA Varela","year":"2023","unstructured":"Varela, V. A. et al. In vitro differentiation of myeloid suppressor cells (MDSC-like) from an immature myelomonocytic precursor THP-1. J. Immunol. Methods 515, 113441 (2023).","journal-title":"J. Immunol. Methods"},{"key":"63271_CR48","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13045-021-01057-7","volume":"14","author":"X Li","year":"2021","unstructured":"Li, X. & Song, Y. Structure, function and inhibition of critical protein-protein interactions involving mixed lineage leukemia 1 and its fusion oncoproteins. J. Hematol. Oncol. 14, 56 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"63271_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1086803","volume":"14","author":"J Lu","year":"2023","unstructured":"Lu, J., Liang, T., Li, P. & Yin, Q. Regulatory effects of IRF4 on immune cells in the tumor microenvironment. Front. Immunol. 14, 1086803 (2023).","journal-title":"Front. Immunol."},{"key":"63271_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.exphem.2022.07.300","volume":"114","author":"S Amanda","year":"2022","unstructured":"Amanda, S., Tan, T. K., Iida, S. & Sanda, T. Lineage- and stage-specific oncogenicity of IRF4. Exp. Hematol. 114, 9\u201317 (2022).","journal-title":"Exp. Hematol."},{"key":"63271_CR51","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.devcel.2015.07.011","volume":"34","author":"S Wang","year":"2015","unstructured":"Wang, S., He, Q., Ma, D., Xue, Y. & Liu, F. Irf4 regulates the choice between T lymphoid-primed progenitor and myeloid lineage fates during embryogenesis. Dev. Cell 34, 621\u2013631 (2015).","journal-title":"Dev. Cell"},{"key":"63271_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1016059","volume":"13","author":"R Fan","year":"2022","unstructured":"Fan, R. et al. The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers. Front Immunol. 13, 1016059 (2022).","journal-title":"Front Immunol."},{"key":"63271_CR53","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/ijlh.12068","volume":"35","author":"BD Hedley","year":"2013","unstructured":"Hedley, B. D. & Keeney, M. Technical issues: flow cytometry and rare event analysis. Int. J. Lab Hematol. 35, 344\u2013350 (2013).","journal-title":"Int. J. Lab Hematol."},{"key":"63271_CR54","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"63271_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"63271_CR56","doi-asserted-by":"publisher","first-page":"W566","DOI":"10.1093\/nar\/gkv468","volume":"43","author":"T Metsalu","year":"2015","unstructured":"Metsalu, T. & Vilo, J. ClustVis: a web tool for visualizing clustering of multivariate data using principal component analysis and heatmap. Nucleic Acids Res 43, W566\u2013W570 (2015).","journal-title":"Nucleic Acids Res"},{"key":"63271_CR57","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26, 1572\u20131573 (2010).","journal-title":"Bioinformatics"},{"key":"63271_CR58","doi-asserted-by":"publisher","first-page":"5735","DOI":"10.1016\/j.csbj.2021.10.020","volume":"19","author":"KA Mullan","year":"2021","unstructured":"Mullan, K. A. et al. ggVolcanoR: a Shiny app for customizable visualization of differential expression datasets. Comput. Struct. Biotechnol. J. 19, 5735\u20135740 (2021).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"63271_CR59","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41586-019-1652-y","volume":"574","author":"DM Popescu","year":"2019","unstructured":"Popescu, D. M. et al. Decoding human fetal liver haematopoiesis. Nature 574, 365\u2013371 (2019).","journal-title":"Nature"},{"key":"63271_CR60","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1093\/nar\/gkt126","volume":"41","author":"Y Shiraishi","year":"2013","unstructured":"Shiraishi, Y. et al. An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data. Nucleic Acids Res 41, e89 (2013).","journal-title":"Nucleic Acids Res"},{"key":"63271_CR61","first-page":"3357","volume":"59","author":"M Reichel","year":"1999","unstructured":"Reichel, M. et al. Rapid isolation of chromosomal breakpoints from patients with t(4;11) acute lymphoblastic leukemia: implications for basic and clinical research. Cancer Res. 59, 3357\u20133362 (1999).","journal-title":"Cancer Res."},{"key":"63271_CR62","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/eji.201970107","volume":"49","author":"A Cossarizza","year":"2019","unstructured":"Cossarizza, A. et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). Eur. J. Immunol. 49, 1457\u20131973 (2019).","journal-title":"Eur. J. Immunol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63271-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63271-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63271-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:47:05Z","timestamp":1757443625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63271-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["63271"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-63271-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"10 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7955"}}